- Previous Close
2.4000 - Open
2.4000 - Bid 2.7700 x 40000
- Ask 3.1500 x 40000
- Day's Range
2.4000 - 2.4000 - 52 Week Range
1.6900 - 2.7800 - Volume
20 - Avg. Volume
66 - Market Cap (intraday)
906.933M - Beta (5Y Monthly) 1.83
- PE Ratio (TTM)
92.67 - EPS (TTM)
0.0300 - Earnings Date Feb 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
www.nanosonics.com.auRecent News: NNCSF
View MorePerformance Overview: NNCSF
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NNCSF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NNCSF
View MoreValuation Measures
Market Cap
906.93M
Enterprise Value
821.84M
Trailing P/E
83.43
Forward P/E
63.69
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.46
Price/Book (mrq)
7.16
Enterprise Value/Revenue
7.04
Enterprise Value/EBITDA
46.38
Financial Highlights
Profitability and Income Statement
Profit Margin
9.00%
Return on Assets (ttm)
3.24%
Return on Equity (ttm)
9.09%
Revenue (ttm)
183.97M
Net Income Avi to Common (ttm)
16.56M
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
144.48M
Total Debt/Equity (mrq)
4.85%
Levered Free Cash Flow (ttm)
24.7M